Novadip Biosciences
Series BNovadip Biosciences raised €40M in a Series B round in Nov 2022. The company is based in Ottignies-Louvain-la-Neuve, Belgium. Investors in the round: CR-CP Life Science Fund, FundPlus, InvestSud and 6 others. Data as of 4 Nov 2026.
Amount raised
€40M
€40,000,000
Native amount
40,000,000 EUR
Stage
Series B
series b
Investors
9
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €40M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
9 namedCR-CP Life Science FundFundPlusInvestSudNew Science VenturesOlivier van der RestPierre DrionSRIW Life SciencesVIVES Louvain Technology FundWalloon Region
Date
Nov 2022
Round type
series b
Amount (EUR)
€40M
Other rounds
same companyRelated news
- Novadip Biosciences Raises Additional EUR 40M in Series B Fundingfinsmes.com · 2022-11